Structure Based Modeling of Small Molecules Binding to the TLR7 by Atomistic Level Simulations
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Structure Based Modeling of Small Molecules Binding to the TLR7 by Atomistic Level Simulations
Authors
Keywords
-
Journal
MOLECULES
Volume 20, Issue 5, Pages 8316-8340
Publisher
MDPI AG
Online
2015-05-08
DOI
10.3390/molecules20058316
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Homology and Molecular Dynamics Models of Toll-Like Receptor 7 Protein and Its Dimerization
- (2014) Chih-Yuan Tseng et al. Chemical Biology & Drug Design
- Imiquimod in the Treatment of Breast Cancer Skin Metastasis
- (2014) Lisa Henriques et al. JOURNAL OF CLINICAL ONCOLOGY
- TLR7/8 agonists trigger immunostimulatory properties of human 6-sulfo LacNAc dendritic cells
- (2013) Hanka Jähnisch et al. CANCER LETTERS
- Processing of Human Toll-like Receptor 7 by Furin-like Proprotein Convertases Is Required for Its Accumulation and Activity in Endosomes
- (2013) Madeleine M. Hipp et al. IMMUNITY
- Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 2. Explicit Solvent Particle Mesh Ewald
- (2013) Romelia Salomon-Ferrer et al. Journal of Chemical Theory and Computation
- Toll-Like Receptor 7 Agonists: Chemical Feature Based Pharmacophore Identification and Molecular Docking Studies
- (2013) Hui Yu et al. PLoS One
- Structural Reorganization of the Toll-Like Receptor 8 Dimer Induced by Agonistic Ligands
- (2013) H. Tanji et al. SCIENCE
- New developments in Toll-like receptor targeted therapeutics
- (2012) Dympna J Connolly et al. CURRENT OPINION IN PHARMACOLOGY
- Resiquimod, a topical drug for viral skin lesions and skin cancer
- (2012) Thomas Meyer et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Homology modeling a fast tool for drug discovery: Current perspectives
- (2012) VK Vyas et al. INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES
- The application of Toll like receptors for cancer therapy
- (2012) Eui Young So et al. International Journal of Biological Sciences
- The Normal-Mode Entropy in the MM/GBSA Method: Effect of System Truncation, Buffer Region, and Dielectric Constant
- (2012) Samuel Genheden et al. Journal of Chemical Information and Modeling
- MMPBSA.py: An Efficient Program for End-State Free Energy Calculations
- (2012) Bill R. Miller et al. Journal of Chemical Theory and Computation
- Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 1. Generalized Born
- (2012) Andreas W. Götz et al. Journal of Chemical Theory and Computation
- Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans
- (2012) Atsuo Ochi et al. JOURNAL OF CLINICAL INVESTIGATION
- Variability in docking success rates due to dataset preparation
- (2012) Christopher R. Corbeil et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- Negative Regulation of the Type I Interferon Signaling Pathway by Synthetic Toll-Like Receptor 7 Ligands
- (2012) Alexandra Forsbach et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Asparagine Endopeptidase Controls Anti-Influenza Virus Immune Responses through TLR7 Activation
- (2012) Sophia Maschalidi et al. PLoS Pathogens
- Toll-Like Receptor 7 Agonist Therapy with Imidazoquinoline Enhances Cancer Cell Death and Increases Lymphocytic Infiltration and Proinflammatory Cytokine Production in Established Tumors of a Renal Cell Carcinoma Mouse Model
- (2012) Eric C. Kauffman et al. Journal of Oncology
- A Point Mutation in the Amino Terminus of TLR7 Abolishes Signaling without Affecting Ligand Binding
- (2011) Carlo Iavarone et al. JOURNAL OF IMMUNOLOGY
- The TLR7 Ligand 9-Benzyl-2-Butoxy-8-Hydroxy Adenine Inhibits IL-17 Response by Eliciting IL-10 and IL-10-Inducing Cytokines
- (2011) A. Vultaggio et al. JOURNAL OF IMMUNOLOGY
- UniProt Knowledgebase: a hub of integrated protein data
- (2011) M. Magrane et al. Database-The Journal of Biological Databases and Curation
- Dual or Triple Activation of TLR7, TLR8, and/or TLR9 by Single-Stranded Oligoribonucleotides
- (2011) Alexandra Forsbach et al. Nucleic Acid Therapeutics
- Assessing the Performance of the MM/PBSA and MM/GBSA Methods. 1. The Accuracy of Binding Free Energy Calculations Based on Molecular Dynamics Simulations
- (2010) Tingjun Hou et al. Journal of Chemical Information and Modeling
- A leucine-rich repeat assembly approach for homology modeling of the human TLR5-10 and mouse TLR11-13 ectodomains
- (2010) Tiandi Wei et al. JOURNAL OF MOLECULAR MODELING
- Additive melanoma suppression with intralesional phospholipid-conjugated TLR7 agonists and systemic IL-2
- (2010) Tomoko Hayashi et al. MELANOMA RESEARCH
- The antiviral activity of toll-like receptor 7 and 7/8 agonists
- (2009) R.L. Miller et al. DRUG NEWS & PERSPECTIVES
- Impaired expression and function of toll-like receptor 7 in hepatitis C virus infection in human hepatoma cells
- (2009) Serena Chang et al. HEPATOLOGY
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
- (2009) Garrett M. Morris et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Homology modeling of human Toll-like receptors TLR7, 8, and 9 ligand-binding domains
- (2009) Tiandi Wei et al. PROTEIN SCIENCE
- CL097, A TLR7/8 LIGAND, INHIBITS TLR-4-DEPENDENT ACTIVATION OF IRAK-M AND BCL-3 EXPRESSION
- (2009) Branka Petricevic et al. SHOCK
- The generalized Born/volume integral implicit solvent model: Estimation of the free energy of hydration using London dispersion instead of atomic surface area
- (2008) Paul Labute JOURNAL OF COMPUTATIONAL CHEMISTRY
- TLR7 and TLR8 as targets in cancer therapy
- (2008) M P Schön et al. ONCOGENE
- The Use of TLR7 and TLR8 Ligands for the Enhancement of Cancer Immunotherapy
- (2008) E. L. J. M. Smits et al. ONCOLOGIST
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now